June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Fluorescence Lifetime Imaging Ophthalmoscopy of mouse models of age-related macular degeneration
Author Affiliations & Notes
  • Yoko Miura
    Institute of Biomedical Optics, University of Lübeck, Lübeck, Germany
    Department of Ophthalmology, University of Lübeck, Lübeck, Germany
  • Britta Lewke
    Institute of Biomedical Optics, University of Lübeck, Lübeck, Germany
  • Erdal Tan Ishizuka
    Institute of Biomedical Optics, University of Lübeck, Lübeck, Germany
  • Svenja Rebecca Sonntag
    Department of Ophthalmology, University of Lübeck, Lübeck, Germany
  • Eric Seifert
    Medical Laser Center Lübeck, Germany
  • Salvatore Grisanti
    Department of Ophthalmology, University of Lübeck, Lübeck, Germany
  • Ralf Brinkmann
    Institute of Biomedical Optics, University of Lübeck, Lübeck, Germany
    Medical Laser Center Lübeck, Germany
  • Footnotes
    Commercial Relationships   Yoko Miura, None; Britta Lewke, None; Erdal Tan Ishizuka, None; Svenja Sonntag, None; Eric Seifert, None; Salvatore Grisanti, None; Ralf Brinkmann, None
  • Footnotes
    Support  BMBF (Federal Ministry of Education and Research): 13N14444, 13N14445
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 365. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yoko Miura, Britta Lewke, Erdal Tan Ishizuka, Svenja Rebecca Sonntag, Eric Seifert, Salvatore Grisanti, Ralf Brinkmann; Fluorescence Lifetime Imaging Ophthalmoscopy of mouse models of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2021;62(8):365.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Fluorescence lifetime (FLT) is a fluorophore-specific property and cellular FLT may be influenced by cell metabolic states. Fluorescence lifetime imaging ophthalmoscopy (FLIO) is a new method that enabled the measurement of FLT of ocular fundus. The purpose of this study was to investigate the fundus FLT of mouse models of retinal degeneration with FLIO.

Methods : Two mouse models of age-related macular degeneration (AMD), apolipoprotein E (ApoE) deficient mice (ApoE-/-) and nuclear factor erythroid 2-related factor 2 (NRF2) deficient mice (Nrf2-/-), and wild type mice (control; C57BL/6J) were investigated monthly from 3 months old (24 mice per strain). Under general anesthesia, slit lamp Ophthalmoscopy, FLIO, optical coherence tomography (OCT) and fundus photography were conducted. The mice were euthanized either at 6 months old or 11 months old. The blood plasma was collected to examine the level of total antioxidant capacity (TAC). The frozen sections of the enucleated eyes were assessed with lipid stainings (Oil Red O).

Results : AMD-like pathological findings (e.g. drusen) were observed after 7 months old in some mice of AMD models. The mean FLT (τm) was generally shortened with age in all groups. Both AMD models showed significantly shorter τm than the control at 4 months old. After that, τm of ApoE-/- mice was further shortened to a larger extent than the control until 11 months old in both spectral channels, whereas Nrf2-/- mice showed an apparently prolonged τm in the long spectrum channel. The strongest lipid staining of the Bruch’s membrane was observed in ApoE-/- mice at 11 months old. The blood TAC of ApoE-/- mice was significantly higher than the control at 6 and 11 months. Nrf2-/- mice showed higher TAC at 6 months old than control, but then decreased and no more difference was found from the control group at 11 months old.

Conclusions : Both mouse models of AMD showed a temporarily shorter fundus FLT than the wild type at a very early time point, presumably owing to the metabolic activation due to stress. After that, however, the fundus FLT of these two strains progressed totally differently over time. The systemic antioxidant capacity could be associated with this difference. These results strongly suggest that FLIO may indicate early changes of metabolic and redox states of the retina prior to the onset of degenerative retinal disorders.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×